A brief history of and future prospects for pneumococcal vaccination in Malaysia

Lister AJJ 1 , Dombay E 1 , Cleary DW 2 , Sulaiman LH 3 , Clarke SC 4

Affiliations 

  • 1 Faculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK
  • 2 Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
  • 3 Centre for Environment and Population Health, Institute for Research, Development, and Innovation, International Medical University, Kuala Lumpur, Malaysia
  • 4 Faculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK. s.c.clarke@soton.ac.uk
Pneumonia (Nathan), 2023 Aug 25;15(1):12.
PMID: 37620925 DOI: 10.1186/s41479-023-00114-8

Abstract

Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme. Data on pneumococcal serotype epidemiology is vital for informing national vaccination policy. However, there remains a lack of representative population-based pneumococcal surveillance in Malaysia to help both the assessment of vaccine effectiveness in the country and to shape future vaccine policy. This review explores the history of pneumococcal vaccination, the burden of pneumococcal disease in Malaysia, and offers an insight into the prospects for reducing pneumococcal disease in Malaysia.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications